Log in to save to my catalogue

Trehalose activates autophagy to alleviate cisplatin-induced chronic kidney injury by targeting the...

Trehalose activates autophagy to alleviate cisplatin-induced chronic kidney injury by targeting the...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11840734

Trehalose activates autophagy to alleviate cisplatin-induced chronic kidney injury by targeting the mTOR-dependent TFEB signaling pathway

About this item

Full title

Trehalose activates autophagy to alleviate cisplatin-induced chronic kidney injury by targeting the mTOR-dependent TFEB signaling pathway

Publisher

Australia: Ivyspring International Publisher

Journal title

Theranostics, 2025-01, Vol.15 (6), p.2544-2563

Language

English

Formats

Publication information

Publisher

Australia: Ivyspring International Publisher

More information

Scope and Contents

Contents

Cisplatin is a potent chemotherapeutic agent limited by significant nephrotoxicity. Multiple cycles of cisplatin administration are necessary to confer chronic disease. Autophagy is a lysosomal degradation pathway that enables the clearance and reuse of cytoplasmic components and is essential for maintaining the integrity and normal physiological f...

Alternative Titles

Full title

Trehalose activates autophagy to alleviate cisplatin-induced chronic kidney injury by targeting the mTOR-dependent TFEB signaling pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11840734

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11840734

Other Identifiers

ISSN

1838-7640

E-ISSN

1838-7640

DOI

10.7150/thno.102559

How to access this item